AI-Powered radiation adjusts in real time to fight brain tumors
NCT ID NCT06492486
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a new way to deliver radiation therapy for people with diffuse glioma, a type of brain tumor. Instead of giving the same dose throughout treatment, doctors will use MRI and PET scans taken during treatment to adjust the radiation dose to target resistant areas and protect healthy tissue. An artificial intelligence system helps plan these adjustments. The trial includes 60 adults aged 18-70 with certain types of glioma. The goal is to see if this adaptive approach improves tumor control and reduces side effects like radionecrosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
adaptive radiotherapy
What this could lead to
If successful, this could make radiation therapy for brain tumors more precise, potentially improving tumor control and reducing side effects.
What could go wrong
This is a small, early-phase trial with only 60 participants. The AI workflow is still being developed, and it's unknown if adaptive dosing will meaningfully improve outcomes or be practical in routine care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••